Piroxicam Beta Cyclodextrin
125 brands · 96 companies · product forms
Opportunity snapshot
Excluded from opportunity ranking — likely noisy resolution.
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 2%
Price room
max/min price ratio 33.68x across 25 trusted points (Rs 22.34-752.4). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(5) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.
Market saturation
96 canonical companies and 125 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 33.68x across 25 trusted points (Rs 22.34-752.4). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2026-06-02 incl. recall/safety.
Confidence
Reduced by: no ATC code.
Packaged brief for this lower opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules